The global veterinary vaccines market is projected to reach USD 12.9 billion by 2027 from USD 8 billion in 2020, at a CAGR of 7.1 % between 2020 and 2027. Anthrax is one of the most common livestock diseases in the world. According to a report published by WHO (World Health Organization), although national programs have resulted in the containment of anthrax globally, it is still prevalent, primarily due to the lack of experience of the most recent generations of veterinarians in identifying and reporting the disease, and the discontinuation of vaccination against the disease.
Livestock diseases are contributing to a set of problems within livestock production systems. These problems include productivity losses, uncertain food security, and loss of income, among others, which are adversely affecting human health. Livestock disease management can reduce disease through the vaccination of animals. Foot-and-mouth disease (FMD) is highly contagious among cloven-hoofed animals, like cattle, swine, sheep, and goats, as well as many species of wild animals. Thus, increasing incidences of livestock diseases are the major factors driving the growth of the veterinary vaccines market, as these diseases can be eradicated with the periodic use of vaccines for animals.
Other factors, which are driving the veterinary vaccines market growth, are rising incidence of zoonotic diseases and initiatives taken by government agencies, animal associations, and leading players.
The market has witnessed an appreciable growth thanks majorly to the sudden climb in pet ownership. This can be attributed to the rising preference of companion animals in single person and nuclear households. Another chief factor responsible for the growth of the market is the growing global demand for quality protein. This and the urge to decrease the use of too many antibiotics in food producing animals have resulted in animal rearers adopting vaccination as the best protective measure. Not only is it far more economical than diagnosing and treating the disease itself, but also mitigates the risk of major disease outbreaks and reduced yield.
Rising concern for animal healthcare in emerging economies has given the market a considerable boost. This and the need to keep a check on zoonotic diseases have established vaccination to be the best measure. While vaccination does provide a cost-effective means to preserving animal health, other factors have limited the market’s growth to some measure (e.g., high (vaccine) maintenance costs, rising meat prices, etc).
The prominent players in the veterinary vaccines market include Zoetis (US), Merck (US), Boehringer Ingelheim (Germany), Elanco (US), Ceva (France), Phibro Animal Health Corporation (US), and Virbac SA (France). Major players have focused on product launches, agreements, and partnerships to increase their shares in the global veterinary vaccines market.
North America has the highest market share. The Centre for Veterinary Biologics (CVB) in the Animal and Plant Health Inspection Service (APHIS) oversees veterinary vaccines in the United States. The CVB gives establishment and drug license to animal health firms to produce and distribute veterinary biologics Vaccination of household animals and wildlife for zoonotic diseases has had a significant effect on reducing the occurrence of zoonotic diseases. In addition, growing understanding of disease prevention and technical developments is expected to fuel demand for veterinary vaccines in the country.
Livestock diseases are contributing to a set of problems within livestock production systems. These problems include productivity losses, uncertain food security, and loss of income, among others, which are adversely affecting human health. Livestock disease management can reduce disease through the vaccination of animals. Foot-and-mouth disease (FMD) is highly contagious among cloven-hoofed animals, like cattle, swine, sheep, and goats, as well as many species of wild animals. Thus, increasing incidences of livestock diseases are the major factors driving the growth of the veterinary vaccines market, as these diseases can be eradicated with the periodic use of vaccines for animals.
Other factors, which are driving the veterinary vaccines market growth, are rising incidence of zoonotic diseases and initiatives taken by government agencies, animal associations, and leading players.
The market has witnessed an appreciable growth thanks majorly to the sudden climb in pet ownership. This can be attributed to the rising preference of companion animals in single person and nuclear households. Another chief factor responsible for the growth of the market is the growing global demand for quality protein. This and the urge to decrease the use of too many antibiotics in food producing animals have resulted in animal rearers adopting vaccination as the best protective measure. Not only is it far more economical than diagnosing and treating the disease itself, but also mitigates the risk of major disease outbreaks and reduced yield.
Rising concern for animal healthcare in emerging economies has given the market a considerable boost. This and the need to keep a check on zoonotic diseases have established vaccination to be the best measure. While vaccination does provide a cost-effective means to preserving animal health, other factors have limited the market’s growth to some measure (e.g., high (vaccine) maintenance costs, rising meat prices, etc).
The prominent players in the veterinary vaccines market include Zoetis (US), Merck (US), Boehringer Ingelheim (Germany), Elanco (US), Ceva (France), Phibro Animal Health Corporation (US), and Virbac SA (France). Major players have focused on product launches, agreements, and partnerships to increase their shares in the global veterinary vaccines market.
North America has the highest market share. The Centre for Veterinary Biologics (CVB) in the Animal and Plant Health Inspection Service (APHIS) oversees veterinary vaccines in the United States. The CVB gives establishment and drug license to animal health firms to produce and distribute veterinary biologics Vaccination of household animals and wildlife for zoonotic diseases has had a significant effect on reducing the occurrence of zoonotic diseases. In addition, growing understanding of disease prevention and technical developments is expected to fuel demand for veterinary vaccines in the country.
- Aerospace and Defense
- Agriculture
- Automotive and Transportation
- Business and Finance
- Chemical and Materials
- Consumer Goods and Retails
- Electronics and Semiconductor
- Energy and Power
- Food and Beverages
- Machinery and Equipment
- Manufacturing and Construction
- Medical Devices
- Pharmaceuticals and Healthcare
- Service and Software
- Technology, Media and Telecommunications
- Travel and Tourism
